Enterprise Solutions

  1. Hybridoma Services 6/5/2026

    Curia’s in vivo Discovery Immunology team offers high-performance hybridoma-based technologies to help clients discover great antibodies that make a difference.

  2. Phage And Yeast Display 6/5/2026

    Curia offers phage and eukaryotic-based yeast display platforms for in vitro discovery and engineering of potent antibody candidates for therapeutic or diagnostic use. High-affinity functional antibodies are routinely selected against a wide range of conventional or challenging targets (e.g. GPCRs) using customized or in-licensed state-of-the-art libraries.

  3. Recombinant Antibody Production 6/5/2026

    Curia has extensive experience with constructing and producing antibodies in our mammalian platforms.

  4. Bacterial Expression 6/5/2026

    E. coli is often the system of choice for biomanufacturing because of its amenability to genetic manipulation, low production cost, and rapid timelines for bioexpression.

  5. Antibody Developability Analysis 6/5/2026

    Evaluating the developability of therapeutic drug candidates early can help circumvent potential issues in late-stage development.

  6. Biological And Functional Assays 6/5/2026

    Curia provides a wide range of biochemical and cell-based bioassay workflows to support Discovery, Research & Development as well as cGxP therapeutic testing campaigns

  7. AAV Production Technology For Scalable, High-Quality Manufacturing 6/5/2026

    Plasmid-free AAV production technology enhances yield, purity, and scalability, enabling cost-efficient manufacturing, reduced variability, and consistent high-quality vectors for gene therapy.

  8. Lentiviral Packaging & Producer Cell Lines For LVV Manufacturing 6/5/2026

    Stable lentiviral vector line platforms enable scalable, cost-efficient manufacturing by reducing plasmids, simplifying processes, improving consistency, and supporting volume production.

  9. 20% Ethanol With WFI In Single Use Bags 6/4/2026

    Formulated to 19.0%–21.0% v/v from USP-grade components, this ready-to-use ethanol solution ships in IPEC/ISO 9001-compliant single-use bags with aseptic dispensing and direct sampling connections built in.

  10. Where Dedication Delivers Value 6/3/2026

    Explore a science-driven CDMO offering end-to-end biologics development and manufacturing, with robust quality, scalable capacity, and expertise from clinical to commercial production.